Updated Jul 16, 2026
SUMER JACQUELYN L has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $176K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | CGEM | Cullinan Therapeutics, Inc. | A — Grant or award | 2.5K | $8.60 | $21K |
| 2026-02-25 | CGEM | Cullinan Therapeutics, Inc. | S — Open-market sale | 3.6K | $14.47 | $52K |
| 2026-02-23 | CGEM | Cullinan Therapeutics, Inc. | S — Open-market sale | 3.7K | $13.62 | $51K |
| 2025-12-19 | CGEM | Cullinan Therapeutics, Inc. | S — Open-market sale | 3.5K | $9.67 | $34K |
| 2024-12-20 | CGEM | Cullinan Therapeutics, Inc. | S — Open-market sale | 3.5K | $11.41 | $40K |
SUMER JACQUELYN L is a corporate insider — currently tracked as Insider of Cullinan Therapeutics, Inc. (CGEM). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($176K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SUMER JACQUELYN L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.